Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Current Opinion in Neurology Année : 2017

Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance

Résumé

Purpose of review Sporadic late-onset nemaline myopathy (SLONM) with monoclonal gammopathy of undetermined significance (MGUS) is a rare subacute progressive muscle disease. The prognosis is poor due to severe respiratory insufficiency. Recently, however, autologous stem-cell transplantation following high-dose melphalan has been shown to be effective unless there is delay before the treatment. Therefore, early recognition of the disease is important. This review gives an overview of recent advances in SLONM–MGUS, which could help to understand clinical and pathological features and treatment.
Fichier principal
Vignette du fichier
URUHA_Akinori.pdf (831.35 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01684027 , version 1 (15-01-2018)

Identifiants

Citer

Akinori Uruha, Olivier Benveniste. Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance. Current Opinion in Neurology, 2017, 30 (5), pp.457 - 463. ⟨10.1097/WCO.0000000000000477⟩. ⟨hal-01684027⟩
112 Consultations
611 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More